Evidence map›Paper›PMID 37654030›Full record

ArticleClinical cardiology2023

Using machine learning to predict adverse events in acute coronary syndrome: A retrospective study.

Long Song, Yuan Li, Shanshan Nie, Zeying Feng, Yaxin Liu, Fangfang Ding, Liying Gong, Liming Liu, Guoping Yang

Open access · goldAbstract read
In one paragraph

Article in Clinical cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Long SongDepartment of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yuan LiXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
Shanshan NieCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zeying FengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
Yaxin LiuXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
Fangfang DingCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liying GongDepartment of Intensive Care Unit, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID http://orcid.org/0000-0002-9569-8450
Liming LiuDepartment of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Guoping YangXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.ORCID http://orcid.org/0000-0001-5930-586X
Central South University · CN

Funding

Hunan Provincial Natural Science Foundation of China 2020JJ5852Key Research and Development Project of Hunan Province 2020SK2010
6 · The paper itself

Abstract

backgroundUp to 30% of patients with acute coronary syndrome (ACS) die from adverse events, mainly renal failure and myocardial infarction (MI). Accurate prediction of adverse events is therefore essential to improve patient prognosis. HYPOTHESIS: Machine learning (ML) methods can accurately identify risk factors and predict adverse events.

methodsA total of 5240 patients diagnosed with ACS who underwent PCI were enrolled and followed for 1 year. Support vector machine, extreme gradient boosting, adaptive boosting, K-nearest neighbors, random forest, decision tree, categorical boosting, and linear discriminant analysis (LDA) were developed with 10-fold cross-validation to predict acute kidney injury (AKI), MI during hospitalization, and all-cause mortality within 1 year. Features with mean Shapley Additive exPlanations score >0.1 were screened by XGBoost method as input for model construction. Accuracy, F1 score, area under curve (AUC), and precision/recall curve were used to evaluate the performance of the models.

resultsOverall, 2.6% of patients died within 1 year, 4.2% had AKI, and 4.7% had MI during hospitalization. The LDA model was superior to the other seven ML models, with an AUC of 0.83, F1 score of 0.90, accuracy of 0.85, recall of 0.85, specificity of 0.68, and precision of 0.99 in predicting all-cause mortality. For AKI and MI, the LDA model also showed good discriminating capacity with an AUC of 0.74.

conclusionThe LDA model, using easily accessible variables from in-hospital patients, showed the potential to effectively predict the risk of adverse events and mortality within 1 year in ACS patients after PCI.

Indexed as

Acute Coronary SyndromeAcute Kidney InjuryMyocardial InfarctionPercutaneous Coronary InterventionHumansMachine LearningRetrospective Studiesacute coronary syndromeAKIall-cause mortalitymachine learningprognosis

Identifiers

PMID37654030
PMCPMC10716319
OpenAlexW4386347637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.